CVS Health Co. (NYSE:CVS - Get Free Report)'s stock price rose 2.7% during trading on Monday after Evercore ISI raised their price target on the stock from $60.00 to $65.00. Evercore ISI currently has an outperform rating on the stock. CVS Health traded as high as $56.77 and last traded at $56.04. Approximately 3,148,189 shares were traded during mid-day trading, a decline of 76% from the average daily volume of 13,225,995 shares. The stock had previously closed at $54.55.
Several other brokerages have also issued reports on CVS. Cantor Fitzgerald restated a "neutral" rating and set a $62.00 price target on shares of CVS Health in a research note on Tuesday, October 1st. Piper Sandler lowered their price target on shares of CVS Health from $72.00 to $64.00 and set an "overweight" rating on the stock in a report on Monday, November 25th. Mizuho reduced their price objective on shares of CVS Health from $73.00 to $66.00 and set an "outperform" rating for the company in a report on Thursday, October 24th. StockNews.com downgraded CVS Health from a "hold" rating to a "sell" rating in a report on Thursday, November 14th. Finally, Deutsche Bank Aktiengesellschaft upgraded CVS Health from a "hold" rating to a "buy" rating and set a $66.00 target price for the company in a research report on Tuesday, December 3rd. One equities research analyst has rated the stock with a sell rating, six have given a hold rating and thirteen have assigned a buy rating to the company. According to MarketBeat, the stock currently has a consensus rating of "Moderate Buy" and an average price target of $68.12.
Check Out Our Latest Stock Analysis on CVS Health
Institutional Inflows and Outflows
Several hedge funds have recently made changes to their positions in the business. Robinson Value Management Ltd. grew its stake in shares of CVS Health by 8.3% during the 4th quarter. Robinson Value Management Ltd. now owns 33,083 shares of the pharmacy operator's stock worth $1,485,000 after acquiring an additional 2,531 shares during the period. Stoneridge Investment Partners LLC boosted its stake in shares of CVS Health by 275.1% during the fourth quarter. Stoneridge Investment Partners LLC now owns 207,651 shares of the pharmacy operator's stock valued at $9,321,000 after purchasing an additional 152,296 shares during the period. Thompson Investment Management Inc. grew its position in shares of CVS Health by 7.8% in the 4th quarter. Thompson Investment Management Inc. now owns 145,783 shares of the pharmacy operator's stock worth $6,544,000 after buying an additional 10,534 shares during the last quarter. Empirical Finance LLC raised its position in shares of CVS Health by 17.8% in the 4th quarter. Empirical Finance LLC now owns 52,588 shares of the pharmacy operator's stock worth $2,361,000 after acquiring an additional 7,959 shares in the last quarter. Finally, Moloney Securities Asset Management LLC boosted its holdings in CVS Health by 2.7% in the fourth quarter. Moloney Securities Asset Management LLC now owns 27,305 shares of the pharmacy operator's stock worth $1,226,000 after acquiring an additional 708 shares in the last quarter. 80.66% of the stock is owned by institutional investors.
CVS Health Trading Up 2.2 %
The company has a quick ratio of 0.59, a current ratio of 0.80 and a debt-to-equity ratio of 0.80. The stock has a market cap of $72.29 billion, a PE ratio of 14.58, a PEG ratio of 0.80 and a beta of 0.59. The stock's fifty day moving average price is $51.24 and its 200 day moving average price is $56.19.
CVS Health (NYSE:CVS - Get Free Report) last announced its quarterly earnings data on Wednesday, November 6th. The pharmacy operator reported $1.09 earnings per share (EPS) for the quarter, topping analysts' consensus estimates of $1.08 by $0.01. CVS Health had a net margin of 1.36% and a return on equity of 10.72%. The firm had revenue of $95.43 billion during the quarter, compared to analysts' expectations of $92.72 billion. During the same period in the prior year, the company posted $2.21 earnings per share. The company's revenue for the quarter was up 6.3% compared to the same quarter last year. On average, sell-side analysts forecast that CVS Health Co. will post 5.22 EPS for the current year.
CVS Health Dividend Announcement
The business also recently declared a quarterly dividend, which will be paid on Monday, February 3rd. Stockholders of record on Thursday, January 23rd will be given a $0.665 dividend. This represents a $2.66 annualized dividend and a dividend yield of 4.63%. The ex-dividend date is Thursday, January 23rd. CVS Health's payout ratio is 67.51%.
CVS Health Company Profile
(
Get Free Report)
CVS Health Corporation provides health solutions in the United States. It operates through Health Care Benefits, Health Services, and Pharmacy & Consumer Wellness segments. The Health Care Benefits segment offers traditional, voluntary, and consumer-directed health insurance products and related services.
Further Reading
Before you consider CVS Health, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and CVS Health wasn't on the list.
While CVS Health currently has a "Moderate Buy" rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Enter your email address and we'll send you MarketBeat's guide to investing in 5G and which 5G stocks show the most promise.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
